This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Gilead Sciences, Inc.. Active years: 2017-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2025
Title: Innovations by Joshua R Dunetz
Introduction
Joshua R Dunetz is an accomplished inventor based in Burlingame, CA (US). He has made significant contributions to the field of pharmaceutical research, particularly in the development of MCL1 inhibitors. With a total of 4 patents to his name, Dunetz has established himself as a key figure in his area of expertise.
Latest Patents
Dunetz's latest patents focus on processes and intermediates for preparing MCL1 inhibitors. The present disclosures provide methods for preparing MCL1 inhibitors or a salt thereof, along with related key intermediates. These innovations are crucial for advancing therapeutic options in cancer treatment.
Career Highlights
Joshua R Dunetz is currently employed at Gilead Sciences, Inc., a leading biopharmaceutical company. His work at Gilead has allowed him to collaborate with other talented professionals in the industry, further enhancing his contributions to innovative drug development.
Collaborations
Some of his notable coworkers include Katrien Brak and Kae M Bullock. Their collaborative efforts have played a significant role in the success of their projects and the advancement of their research.
Conclusion
Joshua R Dunetz is a prominent inventor whose work on MCL1 inhibitors has the potential to impact cancer therapies significantly. His dedication to innovation and collaboration continues to drive advancements in the pharmaceutical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile